Fragile promise of psychedelics in psychiatry
Cédric Lemarchand, Raphaël Chopin, M Paul, Alain Braillon, Lisa Cosgrove, Ioana A. Cristea, Eiko I. Fried, Erick H. Turner, Florian Naudet
BMJ November 19, 2024 DOI: 10.1136/bmj-2024-080391 via OpenAlex
Summary
AI-generated from the abstractThe authors identify weaknesses in the evidence regarding the efficacy and safety of hallucinogens and raise concerns about the use of expedited regulatory pathways for these substances.
Study at a glance
| Characteristics | Review Peer reviewed |
|---|---|
| Keywords | Psychiatry Data science Computer science Medicine World wide web |
| Citations | 9 |
| Key finding | The evidence on hallucinogen efficacy and safety has weaknesses, and the use of expedited regulatory pathways is questionable. |
Abstract
Cédric Lemarchand and colleagues highlight weaknesses in the evidence on efficacy and safety of hallucinogens and question the use of expedited regulatory pathways